Category: Life Sciences
Global Life Sciences
-
Foot Care Products
... at a CAGR of 5.5% over the analysis period 2024-2030. Foot Creams, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$1.4 Billion by the end of ... Read More
-
Colorectal Cancer Therapeutics
... at a CAGR of 6.5% over the analysis period 2024-2030. Targeted Therapy, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$14.9 Billion by the end of ... Read More
-
Amino Acids
... CAGR of 6.0% over the analysis period 2024-2030. Glutamic Acid, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$13.6 Billion by the end of the analysis ... Read More
-
Prescription Drugs
... CAGR of 5.7% over the analysis period 2024-2030. Generics, one of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach US$498.0 Billion by the end of the analysis period. ... Read More
-
Spinal Surgery Products
... at a CAGR of 5.2% over the analysis period 2024-2030. Fusion Product, one of the segments analyzed in the report, is expected to record a 4.8% CAGR and reach US$23.6 Billion by the end of ... Read More
-
Multiple Myeloma Therapeutics
... at a CAGR of 14.5% over the analysis period 2024-2030. Chemotherapy & Other Drugs, one of the segments analyzed in the report, is expected to record a 15.3% CAGR and reach US$37.6 Billion by the ... Read More
-
Radiopharmaceuticals
... 11.0% over the analysis period 2024-2030. Oncology, one of the segments analyzed in the report, is expected to record a 12.6% CAGR and reach US$6.9 Billion by the end of the analysis period. Growth in ... Read More
-
Specialty Enzymes
... CAGR of 4.0% over the analysis period 2024-2030. Protease, one of the segments analyzed in the report, is expected to record a 3.2% CAGR and reach US$2.1 Billion by the end of the analysis period. ... Read More
-
Plastic Films
... CAGR of 5.8% over the analysis period 2024-2030. LLDPE, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$93.5 Billion by the end of the analysis period. ... Read More
-
Industrial Enzymes
... CAGR of 4.3% over the analysis period 2024-2030. Carbohydrases, one of the segments analyzed in the report, is expected to record a 4.3% CAGR and reach US$3.6 Billion by the end of the analysis period. ... Read More
-
Contraceptives
... 6.3% over the analysis period 2024-2030. Drugs, one of the segments analyzed in the report, is expected to record a 6.8% CAGR and reach US$26.0 Billion by the end of the analysis period. Growth in ... Read More
-
Urodynamics Equipment and Disposables
... 2030, growing at a CAGR of 5.4% over the analysis period 2024-2030. Uroflowmetry Equipment, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$106.2 Million by the ... Read More
-
Organ Preservation Solutions
... at a CAGR of 4.9% over the analysis period 2024-2030. Static Cold Storage, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$161.8 Million by the end ... Read More
-
HIV Drugs
... CAGR of 5.2% over the analysis period 2024-2030. Combination HIV Medicines, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$29.0 Billion by the end of the ... Read More
-
Anemia Drugs
... CAGR of 4.1% over the analysis period 2024-2030. Iron Deficiency Anemia, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$7.4 Billion by the end of the ... Read More
-
Calibration Services
... CAGR of 5.6% over the analysis period 2024-2030. Electrical, one of the segments analyzed in the report, is expected to record a 6.5% CAGR and reach US$4.2 Billion by the end of the analysis period. ... Read More
-
H1N1 Vaccines
... CAGR of 5.4% over the analysis period 2024-2030. Intramuscular, one of the segments analyzed in the report, is expected to record a 6.6% CAGR and reach US$1.1 Billion by the end of the analysis period. ... Read More
-
Acute Coronary Syndrome
... at a CAGR of 10.5% over the analysis period 2024-2030. The U.S. Market is Estimated at US$2.6 Billion While China is Forecast to Grow at 16.2% CAGR The Acute Coronary Syndrome market in the U.S. ... Read More
-
Ophthalmology Picture Archiving and Communication Systems
... reach US$211.3 Million by 2030, growing at a CAGR of 6.1% over the analysis period 2024-2030. Integrated PACS, one of the segments analyzed in the report, is expected to record a 6.7% CAGR and reach ... Read More
-
Herpes Simplex Virus Infections
... 2030, growing at a CAGR of 3.9% over the analysis period 2024-2030. The U.S. Market is Estimated at US$1.4 Billion While China is Forecast to Grow at 6.6% CAGR The Herpes Simplex Virus Infections market ... Read More
-
Industrial X-Ray Inspection Systems
... 2030, growing at a CAGR of 6.9% over the analysis period 2024-2030. Digital, one of the segments analyzed in the report, is expected to record a 7.3% CAGR and reach US$916.0 Million by the end ... Read More
-
Biosimulation Technology
... CAGR of 15.6% over the analysis period 2024-2030. Software, one of the segments analyzed in the report, is expected to record a 14.8% CAGR and reach US$5.7 Billion by the end of the analysis period. ... Read More
-
Wearable Medical Devices
... at a CAGR of 17.3% over the analysis period 2024-2030. Diagnostic Devices, one of the segments analyzed in the report, is expected to record a 14.5% CAGR and reach US$41.0 Billion by the end of ... Read More
-
Deep Brain Stimulation Devices
... 2030, growing at a CAGR of 8.5% over the analysis period 2024-2030. Dual-Channel, one of the segments analyzed in the report, is expected to record a 8.1% CAGR and reach US$1.7 Billion by the end ... Read More
-
Dental Preventive Supplies
... at a CAGR of 4.3% over the analysis period 2024-2030. The U.S. Market is Estimated at US$156.3 Million While China is Forecast to Grow at 6.4% CAGR The Dental Preventive Supplies market in the U.S. ... Read More
Research Assistance
